Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Auro Pharmacies, Inc.
WARNING LETTER
•Auro Pharmacies, Inc.•November 5, 2015

Auro Pharmacies, Inc. – FDA Warning Letter, Nov 5, 2015

Record Details

On December 13, 2016, the FDA issued a Warning Letter to Auro Pharmacies, Inc., dba Central Drugs Compounding Pharmacy, following an inspection from September 22 to November 5, 2015. The inspection revealed the firm was producing drug products without valid prescriptions for individually-identified patients and exhibited serious deficiencies in sterile drug product manufacturing, posing patient risks.

Violations included exposing vials to sub-ISO 5 air, poor aseptic practices (e.g., operator placing gloved hands/elbows on ISO 5 hood), failure to use sporicidal agents for disinfection, storing sterilized items without established hold times, and improper fingertip monitoring.

These practices resulted in compounded drugs being unapproved new drugs (violating FDCA Sections 505(a) and 301(d)) and misbranded drugs (violating Sections 502(f)(1) and 301(a)) due to lack of adequate directions for use. Furthermore, sterile drug products were adulterated under Section 501(a)(2)(A) due to insanitary conditions. For drugs compounded without individual prescriptions, the firm was subject to CGMP regulations (21 CFR Parts 210 and 211), and significant CGMP violations were noted, leading to adulteration under Section 501(a)(2)(B). Specific CGMP failures included inadequate procedures for

Company
Auro Pharmacies, Inc.
Inspection date
November 5, 2015
Product type
Drugs
Office
Los Angeles District Office
People
  • Steven E. Porter (Program Division Director)
  • Virginia Harold
View Company Profile

ID · 459fcc32-7cd0-473d-b2ce-b67a1702089b

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 331(k)21 CFR 201.11521 CFR 21021 CFR 21121 CFR 211.113(b)

Full citation text and observation details available on the Dashboard.

Other documents for Auro Pharmacies, Inc.
  • 483 - 2022-08-12August 12, 2022
  • 483 - 2018-08-02August 2, 2018
  • 483 - 2015-11-05November 5, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Auro Pharmacies, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.